Xianping Lv
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Electrospun Nanofibers in Biomedical Applications
- biodegradable polymer synthesis and properties
Papers in
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 2
-
- Circular RNAs in diseases 3
- Co-authors
- Qiankun Yang (8 shared papers)Huifang Jin (6 shared papers)Yanteng Zhao (10 shared papers)Ming Shao (3 shared papers)Yun Chen (4 shared papers)Meng He (4 shared papers)Jing Wang (2 shared papers)Genhao Zhang (3 shared papers)
In The Last Decade
Xianping Lv
18 papers receiving 265 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 113
- Biomaterials 66
- Molecular Medicine 11
- Molecular Biology 137
- Rehabilitation 10
Countries citing papers authored by Xianping Lv
This map shows the geographic impact of Xianping Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianping Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianping Lv more than expected).
Fields of papers citing papers by Xianping Lv
This network shows the impact of papers produced by Xianping Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianping Lv. The network helps show where Xianping Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Xianping Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 45 | |
| 2 | 2018 | 37 | |
| 3 | 2018 | 30 | |
| 4 | 2018 | 30 | |
| 5 | 2019 | 24 | |
| 6 | 2020 | 15 | |
| 7 | 2018 | 15 | |
| 8 | 2018 | 12 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2019 | 8 | |
| 14 | 2021 | 7 | |
| 15 | 2022 | 5 | |
| 16 | 2021 | 2 | |
| 17 | 2024 | 1 | |
| 18 | The mechanism and significance of E-cadherin, anti-apoptosis B-cell lymphoma-2 protein and sE-cadherin roles in cancer. | 2015 | 1 |
| 19 | 2019 | 0 |
About Xianping Lv
Xianping Lv is a scholar working on Cancer Research, Molecular Biology, Biomaterials, Oncology and Biomedical Engineering, having authored 19 papers that have together received 267 indexed citations. Recurring topics across this work include Electrospun Nanofibers in Biomedical Applications (4 papers), Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers), Ferroptosis and cancer prognosis (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Bone Tissue Engineering Materials (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (113 citations), Biomaterials (66 citations), Molecular Medicine (11 citations), Molecular Biology (137 citations) and Rehabilitation (10 citations). Xianping Lv has collaborated with scholars based in China and Canada. Frequent co-authors include Qiankun Yang, Huifang Jin, Yanteng Zhao, Ming Shao, Yun Chen, Meng He, Jing Wang, Genhao Zhang, Hongbing Deng and Jie Song. Their work appears in journals such as Technology in Cancer Research & Treatment, BMC Cancer, Chemical Engineering Journal, Journal of Materials Chemistry B and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.